Skip to content
Skip to content
NUAgo Therapeutics
NUAgo TherapeuticsNUAgo Therapeutics
  • Our Company
  • Our Science
  • Pipeline
  • News & Events
  • Investors & Partnering
  • Contact
  • Our Company
  • Our Science
  • Pipeline
  • News & Events
  • Investors & Partnering
  • Contact

Archives: Publications

You are here:
  1. Home
  2. News & Event

6mer seed toxicity in tumor suppressive miRNAs

By Insight DesignsMarch 4, 2026

The Ratio of Toxic-to-Nontoxic miRNAs Predicts Platinum Sensitivity in Ovarian Cancer

By Insight DesignsMarch 4, 2026
NUAgo Therapeutics

NUAgo Therapeutics

303 E Superior St
Chicago IL 60611

contactNUAgo@NUAgotherapeutics.com

Privacy Policy Terms of Use Accessibility
© 2026 Nuago Therapeutics.
LinkedIn YouTube
Go to Top